Alerts will be sent to your verified email
Verify EmailBRAWN
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Brawn Biotech Ltd is a pharmaceutical company engaged in manufacturing tablets, capsules, and oral syrups across various categories including Analgesics, Antibiotics, and Cardiovascular drugs.
Brawn Biotech major competitors are PM Telelinks, PAE, Lexoraa Industries, Aviva Inds, Centron Indl. Allian, Ashiana Agro, Voltaire Leasing.
Market Cap of Brawn Biotech is ₹6 Crs.
While the median market cap of its peers are ₹5 Crs.
Brawn Biotech seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.